Skip to main content
PLOS One logoLink to PLOS One
. 2018 Jul 26;13(7):e0201292. doi: 10.1371/journal.pone.0201292

Rehabilitation for patients with sepsis: A systematic review and meta-analysis

Shunsuke Taito 1,*, Mahoko Taito 2, Masahiro Banno 3,4, Hiraku Tsujimoto 5, Yuki Kataoka 5,6, Yasushi Tsujimoto 7,8
Editor: Juan Carlos Lopez-Delgado9
PMCID: PMC6062068  PMID: 30048540

Abstract

The objective of this systematic review was to determine whether rehabilitation impacts clinically relevant outcomes among adult patients with sepsis. Randomized controlled trials from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PEDro, and the World Health Organization International Clinical Trials Platform Search Portal, as well as conference proceedings and reference lists of relevant articles were collected. Two reviewers independently identified randomized controlled trials on the rehabilitation of patients with sepsis, and the two reviewers independently abstracted trial level data including population characteristics, interventions, comparisons, and clinical outcomes. Our primary outcomes were quality of life (QOL), activity of daily living (ADL), and mortality. Our secondary outcomes were length of stay, return to work, muscle strength, delirium, and all adverse events. The quality of evidence was determined using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. We included two trials enrolling 75 patients. The mean difference (95% confidence interval [CI]) of physical function and physical role in QOL measured by SF-36 were 21.10 (95% CI: 6.57–35.63) and 44.40 (95% CI: 22.55–66.05), respectively. Rehabilitation did not significantly decrease intensive care unit (ICU) mortality (risk ratio, 2.02 [95% CI: 0.46–8.91], I2 = 0%; n = 75). ICU length of stay and hospital length of stay and muscle strength were not statistically significantly different and no adverse events were reported in both studies. The certainty of the evidence for these outcomes was “very low.” Data on ADL, return to work, and delirium were not available in any of the trials. Rehabilitation of patients with sepsis might not decrease ICU mortality, but might improve QOL. Further, well-designed trials measuring important outcomes will be needed to determine the benefit and harm of rehabilitation among patients with sepsis.

Introduction

Sepsis is a major healthcare problem, affecting millions of people around the world each year [1]. Sepsis was identified in 6.0% of all adult patients admitted to hospitals in the United States, among whom 15.0% died on admission and 6.2% were discharged to hospice care [2]. The readmission rate in patients with sepsis following discharge was reported as 35% within 6 months and 60% within a year [3, 4]. It has also been reported that after discharge, one-third of patients with a diagnosis of sepsis had not returned to independent living after 6 months [5]. Furthermore, the long-term health-related quality of life (QOL) outcomes in such patients were poorer than in other populations [6, 7]. Guidelines recommend that critically-ill patients undergo rehabilitation in an intensive care unit (ICU) [8, 9]. Recent randomized controlled studies have reported that rehabilitation reduced the incidence of delirium, and improved physical function and activities of daily living (ADL) in ICU patients [10]. Rehabilitation also provides additional advantages, including improvement in psychological and cognitive functions, promotion of social participation, and increase in the opportunity to return to work [1113]. Physical rehabilitation is an important strategy for enhancing recovery from critical illness and for improving the symptoms of post-intensive care syndrome (PICS) [13].

In a recent systematic review and meta-analysis [14] of critically-ill patients, rehabilitation had no impact on QOL and mortality. A pilot randomized controlled trial (RCT) of patients with sepsis in ICU reported that rehabilitation improved QOL [15], and a larger effect of rehabilitation may be expected for such patients with sepsis. This review [14] only included trials in ICU settings. However, patients with sepsis are also treated in non-ICU wards, and the classification of wards differs among countries [16]. One of the goals of the Global Sepsis Alliance [17] is “ensuring improved access to adequate rehabilitation services” [18]. However, no systematic reviews and meta-analyses have yet reported the effect of rehabilitation in patients with sepsis. Therefore, the objective of our study was to determine whether rehabilitation impacts clinically relevant outcomes, compared with usual care, among adult patients with sepsis.

Materials and methods

Using a pre-specified published protocol (PROSPERO: CRD42017076384) [19], we conducted a systematic review based on the Cochrane Handbook [20] and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines [21]. We assessed this systematic review using the PRISMA 2009 checklist [22]. An additional file shows this in more detail (S1 File. PRISMA 2009 Checklist).

Research question and eligibility criteria

We posed the following research question: “In adult patients with sepsis, does rehabilitation compared with usual care result in improved clinically relevant outcomes?” We included all published and unpublished prospective RCTs in human subjects who were adults (aged ≥18 years) with sepsis (defined by the international guideline [2326] or authors’ definitions, including those that were only abstracts or letters. Crossover trials and cluster-, quasi-, or non-randomized trials were excluded. Studies were included regardless of the time of follow-up. We included patients of any sex, race, and setting, and excluded those with head or spinal cord injury, and unstable fractures contributing to probable immobility. The intervention in the review was protocolized rehabilitation in hospitals, including neuromuscular stimulation, passive range of motion exercise, or active exercises, designed to either commence earlier and/or be more intensive than the care received by the control group. Any combination of one or more of the following were considered: neuromuscular stimulation, inspiratory or respiratory muscle training, passive range of motion exercise, cycle ergometry, active-assisted exercises, mobility activities in bed, ADLs, transfer, marching on the spot, and walking exercise. Our primary outcomes were QOL, ADL assessed using standard measures such as function independence measures and the Barthel index, and mortality. Secondary outcomes were length of stay (ICU and hospital), return to work, muscle strength, delirium, and all adverse events (defined by the trialists).

Search strategy and selection of studies

We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE via Ovid, EMBASE via Elsevier, PEDro, and the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) on September 18, 2017. We re-ran the search using the Cumulative Index to Nursing and Allied Health Literature (CINAHL) via EBSCO on May 26, 2018. An additional file shows this process in more detail (S2 File. Search Strategy). We also hand-searched reference lists for the latest guidelines on sepsis [26], as well as reference lists of extracted studies and articles citing extracted studies, using the Web of Science. We contacted authors of extracted studies if these studies lacked necessary information. Two reviewers (ST and MT) independently screened titles and abstracts of search results to determine whether each citation met the inclusion criteria. They assessed the eligibility based on a full-text review. Disagreement was resolved by discussion, and if necessary, YT was brought in for arbitration.

Data abstraction and quality assessment

Two reviewers (ST and MT) also independently abstracted trial level data using pre-specified forms. Disagreements in data extraction were resolved through discussions. We contacted authors of studies without sufficient information where necessary. Two reviewers (ST and MT) independently assessed the risk of bias in the included studies using the Cochrane Risk of Bias Assessment Tool [20]. Differences in opinion following the assessment of risk of bias were resolved through discussions, and where this failed, through arbitration by YT.

Data analysis

All analyses were conducted using the Review Manager software (RevMan 5.3; Cochrane Community). We pooled the risk ratio (RR) with 95% confidence interval (CI) for the dichotomous variables: mortality and return to work. For continuous outcomes—QOL, ADL, length of stay (ICU and hospital), muscle strength, delirium days (ICU and hospital), the standardized mean difference (SMD), or mean differences (MD) with 95% CI were calculated, as recommended by the Cochrane Handbook [18]. Adverse events were narratively summarized because the definition of these outcomes varied from study to study. We used the random-effects models for all analyses. To explore potential heterogeneity and determine whether the level of risk of bias affected the effect estimate, we planned to conduct subgroup and sensitivity analyses. However, the included studies were insufficient to perform these analyses. We investigated the reporting bias by checking the trial registers (WHO ICTRP) and detected completed but unpublished trials. P<0.05 was considered statistically significant. The summary of findings is presented in Table 1, which includes an overall grading of the evidence using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach [27, 28].

Table 1. Summary of findings.

Outcome Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evidence
(GRADE)
Comments
Risk usual care Risk rehabilitation
Quality of life
SF-36 (at 6 months)
Mean difference [95% CI] of physical function and physical role were 21.10 [6.57–35.63] and 44.40 [22.55–66.05] respectively. These mean differences were significantly higher for those who received intervention. - 30
(1 RCT)
⊕⊝⊝⊝
Very low a b c
ICU mortality Study population RR 2.02
(0.46 to 8.91)
75
(2 RCT)
⊕⊝⊝⊝
Very low b c
65 per 1,000 130 per 1,000 (30 to 575)
ICU length of stay Median (interquartile range) of ICU length of stay was not statistically significantly different in both studies.
Intervention vs. comparison: 12 (4–45) vs. 8.5 (3–36) days
- 50
(1 RCT)
⊕⊝⊝⊝
Very low a b c
Hospital length of stay Hospital length of stay was not statistically significantly different in both studies.
Intervention vs. comparison: 41 (9–158) vs. 45 (14–308) days and 30 (18–45) vs. 36 (26–78) days
- 75
(2 RCT)
⊕⊝⊝⊝
Very low a b c
Muscle strength
MRC sum-score (at ICU discharge)
Mean difference [95% CI] of MRC sum-score was 4.6 [-2.69–11.89]. The mean difference was higher for those who received intervention. - 42
(1 RCT)
⊕⊝⊝⊝
Very low a b c
Adverse events Two studies reported no adverse events. - 75
(2 RCT)
⊕⊝⊝⊝
Very low a b c

*The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: confidence interval; RR: risk ratio

GRADE Working Group grades of evidence

High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.

Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.

Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of the effect.

a Participants and personnel were not blinded.

b Number of participants was small.

c There were four ongoing studies.

Results

Study selection, characteristics and quality

Of 1,684 citations retrieved, we included two unique RCTs (Fig 1 and Table 2) [15, 29]. In total, 75 patients were represented across the two studies (44 interventions and 31 controls). Both trials evaluated the effect of rehabilitation in an ICU setting. The median ages of the patients were 62.5 (inter-quartile range [IQR]: 30–83) and 77.5 (72–81) years, respectively. The mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 28.0 (standard deviation [SD]: 7.6) and median: 23.5 (IQR: 19–28). The interventions in the included studies were provided over 5 times per week and ranged from 30 to 60 min of therapy per day in ICUs. These interventions mainly involved passive or active assisted exercise and neuromuscular stimulation.

Fig 1. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow diagram.

Fig 1

Table 2. Characteristics of included studies.

Author, Year, Country Setting No of participants Study type Intervention (contents, frequency) Control (standard care) Outcomes Note
Kayambu G et al., 2015, Australia ICU 50
(intervention: 26, control: 24)
Pilot RCT Intervention for 30 min, one to two times daily until discharge from the ICU within 48 h of the diagnosis of sepsis. Physical rehabilitation strategies included electrical muscle stimulation, passive range of motion, active range of motion, sitting out of bed, transfers, ambulation and other mobilization techniques. Usual care (standard ICU care which included physical therapy strategies provided by the ICU physiotherapist). Physical function (acute care index of function) and self-reported health-related quality of life) at ICU discharge and 6 months posthospital discharge, inflammatory biomarkers (interleukin-6, interleukin-10 and tumor necrosis factor-α), blood lactate, fat free muscle mass, exercise capacity, muscle strength and anxiety, ICU mortality, 30-day mortality, ICU length of stay, hospital length of stay, and adverse events. The protocol is published (BMC Anesthesiol. 2011 Oct 31;11:21)
Trial ID: ACTRN 12610000808044
Shen SY et al., 2017, Taiwan ICU 25
(intervention: 18, control: 7)
Pilot RCT In addition to usual care, electrical muscle stimulation on both quadriceps (vastus medialis) and biceps, 32 minutes per day, 5 days per week (Monday to Friday) until discharge from the ICU after patients required mechanical ventilation longer than 72 hours. Usual care (active or passive exercise of extremities which was decided and performed by the physical rehabilitation therapist after consultation). ICU mortality*, hospital mortality, mechanical ventilation days, successful spontaneous breathing, and adverse events. Trial ID: NCT01895647A

*Unpublished data

We identified four studies as ongoing and confirmed the trial status through direct contact with the lead authors. The characteristics of these ongoing studies, including details of participants, interventions, control group, and outcomes are summarized in an additional file (S1 Table. Characteristics of ongoing studies). Briefly, participants included from ongoing studies were patients diagnosed with sepsis, severe sepsis, or septic shock. The interventions included additional physical therapy including passive/active cycling exercise, functional electrical stimulation, and early mobilization. QOL, ADL, mortality, length of stay in hospital or ICU, employment status, and muscle strength were included as outcomes in these trials. No further articles were found from hand searches.

The risk of bias assessment is outlined in Table 3. In both studies, participants and personnel were not blinded to the intervention. Also, the studies had incomplete outcomes and selective reporting. Shen’s study reported unknown risk of bias from published data, and as such, we contacted the authors. According to the authors, nurses not part of the study drew lots and the investigator was not aware of the randomization sequence, but there was no blinding of the outcome assessment. One study was funded by the Intensive Care Foundation.

Table 3. Assessment of risk of bias in included trials.

Trial Random sequence generation Allocation concealment Blinding of participants and personnel Blinding of outcome assessment Incomplete outcome data Selective reporting Other biases
Kayambu et al. [15] Low Low High Low High High Low
Shen et al. [29] Low Low High High High High Unknown*

*: Very little detail given regarding the therapy received in the control group

The main results of our review are presented in Table 1.

Primary outcomes

Data on QOL were available in 1 of the 2 trials [15], while data on ADL were not available in any of the trials. ICU mortality was reported in both trials [15, 29]. Mean difference (95% CI) of physical function and physical role in QOL were 21.10 (6.57–35.63) and 44.40 (22.55–66.05), respectively. Rehabilitation did not significantly decrease ICU mortality (RR, 2.02; 95% CI, 0.46–8.91, I2 = 0%; n = 75) (Fig 2). The certainty of the evidence for QOL and ICU mortality were “very low” (Table 1).

Fig 2. Effect of rehabilitation on ICU mortality.

Fig 2

Secondary outcomes

There was no significant differences in ICU length of stay and hospital length of stay between the intervention and control groups in both studies [15, 29]. The data on muscle strength were available in 1 of 2 trials [15], and the mean difference (95% CI) of MRC sum-score was 4.60 (-2.69–11.89) and higher among those who received intervention.

Data on return to work and delirium were not available in any of the trials. Both studies reported no adverse event in both the intervention and standard care groups.

Discussion

We observed no reduction in ICU mortality among patients with sepsis who received rehabilitation. Rehabilitation could improve QOL but did not improve hospital length of stay or muscle strength, although data for these outcomes were limited. Studies on the rehabilitation of patients with sepsis are very few, and the certainty of the evidence was very low, from the findings of this systematic review.

Rehabilitation of patients with sepsis might improve QOL but might not decrease ICU mortality compared with standard care based on two studies which had wide confidence intervals and small sample sizes. This was different from a recent systematic review of critically-ill patients [14] which reported that the mean difference (95% CI) of physical function and physical role in QOL measured by SF-36 were 6.44 (-4.57–417.45) and 17.33 (-13.10–147.76), respectively and the risk difference (95% CI) of ICU mortality from eight studies was 0.02 [-0.01–0.05]. The review [14] determined the effect of rehabilitation in ICU among patients regardless of disease and our review was like a subgroup analysis of the review. Sepsis is a high risk factor for PICS such as ICU-acquired weakness and delirium [30, 31], and is associated with high mortality [2] and readmission rates [3, 4]. Physical rehabilitation is an important strategy for enhancing the recovery of critically-ill patients and for addressing the symptoms of PICS [13]. Thus, we thought that sepsis patients respond to rehabilitation differently and might truly benefit from physical rehabilitation. Rehabilitation might improve QOL for only sepsis patients in the ICU although the pilot studies had high risks of bias. On the other hand, some studies for other illnesses, including the exacerbation of chronic respiratory disease [32] and stroke [33] reported that early intensive rehabilitation may increase mortality and unfavorable outcomes. There are several ongoing studies, and further studies with low risk of bias are needed to further investigate this.

The main purpose of rehabilitation in the ICU is to improve QOL by maintaining, improving, and reacquiring ADL [34], including returning to work for survivors after hospital discharge. Sepsis is a risk factor for PICS [13] such as ICU-acquired weakness [35] and delirium [36] which are associated with QOL [37, 38]. Thus, we selected these outcomes to determine the effect of rehabilitation in patients with sepsis; however, ADL and delirium were not reported. Recently, the need for consensus on core outcomes set for patients with sepsis was agreed upon [39], and medical staff, patients, and caregiver representatives set core outcomes for acute respiratory failure survivors [40, 41]. Ongoing studies investigating ADL and employment status [42] will reveal the core outcomes needed for patients with sepsis, with respect to rehabilitation after hospital discharge, including ADL, delirium, and returning to work [43].

Generalizability of rehabilitation for patients with sepsis in ICU may be poor. Only approximately 5% of patients screened were included [15, 29] and there were also large differences between the number of participants recruited and the planned recruitment. The large difference between the number of participants recruited and those originally planned to be recruited was not only a potential feasibility issue in conducting trials in patients with sepsis but also the timing of the commencement of the intervention in which patients were managed by mechanical ventilation. Both reviewed studies included neuromuscular stimulation and needed stimulators for intervention. Thus, not all facilities could provide the intervention. Secondly, intensive rehabilitation could increase work burden for physicians, nurses, and physical therapists. The interventions in the included studies started in the ICU, and highly professional interventions based on adequate assessment were needed for critically-ill patients in the ICU. Except for facilities with adequate well-trained human resources, there are concerns about the feasibility of rehabilitation in the ICU. There is the need for clinical trials about more feasible interventions.

This review did not include trials in non-ICU settings because the reviewed studies were only conducted in ICU settings. A few studies reported on the rehabilitation of critically-ill patients after ICU discharge [44], and an ongoing study is examining the effect of intervention after hospital discharge [45]. However, there might be differences in the effect of rehabilitation on patients with low disease severity, and further studies are needed to examine the effect of rehabilitation in non-ICU settings.

This systematic review has potential limitations. We only included two RCTs in this review, and we might not have searched exhaustively. However, we tried to enhance the comprehensiveness in this review by identifying more studies by searching other sources and performing citation search. The trials were at high risk of bias due to the lack of blinding in the intervention arms, which may have contributed to performance bias. Mortality might not be affected by performance bias, but other outcomes such as the QOL and muscle strength could be affected by the bias.

Conclusions

Rehabilitation of patients with sepsis might not decrease ICU mortality nor improve the length of stay in hospital and muscle strength, but could improve QOL compared with standard care based on two studies which had wide confidence intervals and small sample sizes. However, data for these outcomes were limited and future well-designed prospective randomized controlled trials with a low risk of bias to provide definitive conclusions on this topic are needed.

Supporting information

S1 File. PRISMA 2009 checklist.

(DOC)

S2 File. Search strategy.

(DOCX)

S1 Table. Characteristics of ongoing studies.

(DOCX)

Acknowledgments

We thank Jennifer Paratz, Kuang-Hua Cheng, Pierre-François Laterre and Selina M Parry for the provision of information about their studies.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was supported by JSPS KAKENHI Grant Number JP18K17719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010;376(9749):1339–46. 10.1016/S0140-6736(10)60446-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009–2014. JAMA. 2017;318(13):1241–9. 10.1001/jama.2017.13836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Perner A, Haase N, Winkel P, Guttormsen AB, Tenhunen J, Klemenzson G, et al. Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer’s acetate. Intensive Care Med. 2014;40(7):927–34. 10.1007/s00134-014-3311-y [DOI] [PubMed] [Google Scholar]
  • 4.Mayr FB, Talisa VB, Balakumar V, Chang CH, Fine M, Yende S. Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions. JAMA. 2017;317(5):530–1. 10.1001/jama.2016.20468 [DOI] [PubMed] [Google Scholar]
  • 5.Yende S, Austin S, Rhodes A, Finfer S, Opal S, Thompson T, et al. Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials. Crit Care Med. 2016;44(8):1461–7. 10.1097/CCM.0000000000001658 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Battle CE, Davies G, Evans PA. Long term health-related quality of life in survivors of sepsis in South West Wales: an epidemiological study. PloS One. 2014;9(12):e116304 10.1371/journal.pone.0116304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cuthbertson BH, Elders A, Hall S, Taylor J, MacLennan G, Mackirdy F, et al. Mortality and quality of life in the five years after severe sepsis. Crit Care. 2013;17(2):R70 10.1186/cc12616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.National Institute for Health and Care Excellence: Rehabilitation after critical illness. https://www.nice.org.uk/guidance/cg83. Cited 24 May 2018. [PubMed]
  • 9.Girard TD, Alhazzani W, Kress JP, Ouellette DR, Schmidt GA, Truwit JD, et al. An Official American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults. Rehabilitation Protocols, Ventilator Liberation Protocols, and Cuff Leak Tests. Am J Respir Crit Care Med. 2017;195(1):120–33. 10.1164/rccm.201610-2075ST [DOI] [PubMed] [Google Scholar]
  • 10.Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874–82. 10.1016/S0140-6736(09)60658-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hopkins RO, Suchyta MR, Farrer TJ, Needham D. Improving post-intensive care unit neuropsychiatric outcomes: understanding cognitive effects of physical activity. Am J Respir Crit Care Med. 2012;186(12):1220–8. 10.1164/rccm.201206-1022CP [DOI] [PubMed] [Google Scholar]
  • 12.Schaller SJ, Anstey M, Blobner M, Edrich T, Grabitz SD, Gradwohl-Matis I, et al. Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial. Lancet. 2016;388(10052):1377–88. 10.1016/S0140-6736(16)31637-3 [DOI] [PubMed] [Google Scholar]
  • 13.Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40(2):502–9. 10.1097/CCM.0b013e318232da75 [DOI] [PubMed] [Google Scholar]
  • 14.Tipping CJ, Harrold M, Holland A, Romero L, Nisbet T, Hodgson CL. The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review. Intensive Care Med. 2017;43(2):171–83. 10.1007/s00134-016-4612-0 [DOI] [PubMed] [Google Scholar]
  • 15.Kayambu G, Boots R, Paratz J. Early physical rehabilitation in intensive care patients with sepsis syndromes: a pilot randomised controlled trial. Intensive Care Med. 2015;41(5):865–74. 10.1007/s00134-015-3763-8 [DOI] [PubMed] [Google Scholar]
  • 16.Govindan S, Iwashyna TJ, Odden A, Flanders SA, Chopra V. Mobilization in severe sepsis: an integrative review. J Hosp Med. 2015;10(1):54–9. 10.1002/jhm.2281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stehr SN, Reinhart K. Sepsis as a global health problem-why we need a global sepsis alliance. Shock. 2013;39(Suppl 1):3–4. [DOI] [PubMed] [Google Scholar]
  • 18.Reinhart K, Daniels R, Machado FR. The burden of sepsis: a call to action in support of World Sepsis Day 2013. Rev Bras Ter Intensiva. 2013;25(1):3–5. 10.1590/S0103-507X2013000100002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Taito S, Taito M, Banno M, Tsujimoto H, Kataoka Y, Tsujimoto Y. A systematic review and meta-analysis of rehabilitation in patients with sepsis. PROSPERO International Prospective Register of Systematic Reviews; 2017 [cited 2018 Jan 13]. https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=76384
  • 20.Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 London: The Cochrane Collaboration; 2011. [Google Scholar]
  • 21.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med. 2009;6(7):e1000100 10.1371/journal.pmed.1000100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097 10.1371/journal.pmed.1000097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864–74. [PubMed] [Google Scholar]
  • 24.Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250–6. 10.1097/01.CCM.0000050454.01978.3B [DOI] [PubMed] [Google Scholar]
  • 25.Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. 10.1097/CCM.0b013e31827e83af [DOI] [PubMed] [Google Scholar]
  • 26.Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10. 10.1001/jama.2016.0287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924–6. 10.1136/bmj.39489.470347.AD [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64(4):383–94. 10.1016/j.jclinepi.2010.04.026 [DOI] [PubMed] [Google Scholar]
  • 29.Shen SY, Lee CH, Lin RL, Cheng KH. Electric Muscle Stimulation for Weaning from Mechanical Ventilation in Elder Patients with Severe Sepsis and Acute Respiratory Failure—A Pilot Study. Int J Gerontol. 2017;11(1):41–5. [Google Scholar]
  • 30.Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33(11):1876–91. 10.1007/s00134-007-0772-2 [DOI] [PubMed] [Google Scholar]
  • 31.Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94. 10.1001/jama.2010.1553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Greening NJ, Williams JEA, Hussain SF, Harvey-Dunstan TC, Bankart MJ, Chaplin EJ, et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ. 2014;349:g4315 10.1136/bmj.g4315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.AVERT Trial Collaboration group. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015;386(9988):46–55. 10.1016/S0140-6736(15)60690-0 [DOI] [PubMed] [Google Scholar]
  • 34.Hodgson CL, Udy AA, Bailey M, Barrett J, Bellomo R, Bucknall T, et al. The impact of disability in survivors of critical illness. Intensive Care Med. 2017;43(7):992–1001. 10.1007/s00134-017-4830-0 [DOI] [PubMed] [Google Scholar]
  • 35.Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar A, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27(8):1288–96. [DOI] [PubMed] [Google Scholar]
  • 36.Pandharipande PP, Ely EW, Arora RC, Balas MC, Boustani MA, La Calle GH, et al. The intensive care delirium research agenda: a multinational, interprofessional perspective. Intensive Care Med. 2017;43(9):1329–39. 10.1007/s00134-017-4860-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Fan E, Dowdy DW, Colantuoni E, Mendez-Tellez PA, Sevransky JE, Shanholtz C, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med. 2014;42(9):849–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Naidech AM, Beaumont JL, Rosenberg NF, Maas MB, Kosteva AR, Ault ML, et al. Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohort. Am J Respir Crit Care Med. 2013;188(11):1331–7. 10.1164/rccm.201307-1256OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Scudeller L, Silvestri AD, Seminari E, Pagnucco L, Signorini L, Suardi L, et al. Study protocol: systematic overview of outcomes used in systematic reviews on interventions for sepsis and/or bloodstream infections. PROSPERO International Prospective Register of Systematic Reviews 2017 [cited 2018 Jan 13]. https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=16617.
  • 40.Turnbull AE, Sepulveda KA, Dinglas VD, Chessare CM, Bingham CO 3rd, Needham DM. Core Domains for Clinical Research in Acute Respiratory Failure Survivors: An International Modified Delphi Consensus Study. Crit Care Med. 2017;45(6):1001–10. 10.1097/CCM.0000000000002435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Needham DM, Sepulveda KA, Dinglas VD, Chessare CM, Friedman LA, Bingham CO 3rd, et al. Core Outcome Measures for Clinical Research in Acute Respiratory Failure Survivors. An International Modified Delphi Consensus Study. Am J Respir Crit Care Med. 2017;196(9):1122–30. 10.1164/rccm.201702-0372OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Rohde J. Sepsis Trial of Early Physical Therapy Outside the ICU (STEP TO IT) [cited 2018 Jan 13]. https://clinicaltrials.gov/ct2/show/NCT02159222.
  • 43.Major ME, Kwakman R, Kho ME, Connolly B, McWilliams D, Denehy L, et al. Surviving critical illness: what is next? An expert consensus statement on physical rehabilitation after hospital discharge. Crit Care. 2016;20:354 10.1186/s13054-016-1508-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Connolly B, Salisbury L, O’Neill B, Geneen L, Douiri A, Grocott MPW, et al. Exercise rehabilitation following intensive care unit discharge for recovery from critical illness: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2016;7(5):520–6. 10.1002/jcsm.12146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Paratz JD, Kenardy J, Mitchell G, Comans T, Coyer F, Thomas P, et al. IMPOSE (IMProving Outcomes after Sepsis)—the effect of a multidisciplinary follow-up service on health-related quality of life in patients postsepsis syndromes—a double-blinded randomised controlled trial: protocol. BMJ Open. 2014;4(5):e004966 10.1136/bmjopen-2014-004966 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. PRISMA 2009 checklist.

(DOC)

S2 File. Search strategy.

(DOCX)

S1 Table. Characteristics of ongoing studies.

(DOCX)

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES